Jennifer Byrne (research scientist)

Last updated

Jennifer Byrne
JAB headshot 2020 no glasses cropped.jpg
Born
Jennifer Anne Byrne

1966 (age 56–57)
Alma mater University of Queensland
Scientific career
Institutions University of Sydney
NSW Health Pathology
Thesis The structure of the human ribonucleoside diphosphate reductase M1 subunit gene, and the use of this locus in studies of embryonal tumours (1993)

Jennifer Anne Byrne (born 1966) [1] is a Professor of Molecular Oncology at University of Sydney, Australia. Byrne is notable for not only her cancer research, but the uncovering of academic fraud and junk science in cancer research. [2]

Contents

As a result of her and her colleague's investigations, 17 papers have been retracted, and others have been noted. [3] As a result, the journal Nature rated Byrne as one of their "Ten people who mattered" in 2017.

Education

Byrne matriculated from St Margaret's Anglican Girls' School in Brisbane in 1983. She graduated from with a BSc and PhD (1993) from the University of Queensland. [4] [1]

Research interests

Byrne has spent her career investigating adult and childhood cancer. She specializes in biobanking, cancer genetics as well as research integrity. [5] Her PhD involved mapping the loss of the chromosome 11p15 loci in embryonal tumours. [6]

Career

Byrne is currently (2020) employed by NSW Health Pathology as the Director of Biobanking. She leads the NSW Health biobanking program, including the NSW Health Statewide Biobank (NSWHSB). Her other positions include Professor of Molecular Oncology, at the School of Medical Sciences, at the University of Sydney. In addition, Byrne was previously the Deputy Director of a group called the Kids Cancer Alliance, which is a Translational Cancer Research Center within the Cancer Institute of NSW. [6]

Fraud investigation

While reading scientific articles on cancer research, Byrne noticed odd patterns in publications about a particular gene. The papers described 'strikingly similar' experiments on a gene that has been linked with childhood leukemia and breast cancer. She recognized the particular gene, because she had previously led the team that had cloned the gene 20 years earlier. [7]

Her experience on that gene made her realize that all of the papers, which were all from China, were describing the same nucleotide sequence yet some of the papers were describing this sequence wrongly. A nucleotide sequence is the specific order of letters which describes how a particular piece of DNA is composed. She noticed that the papers were describing wrong nucleotide sequences in the context of laboratory experiments performed with cancer cell lines. These wrong sequences implies that: (1) either the studies were not examining what they reported, or (2) the experiments had not been conducted as described. The implication is that each paper contains the seeds of bad research, that other papers could possibly build upon. [2]

Further evidence of fraud or junk science was suggested as other papers used the same sequences for the opposite purposes. This means that "a sequence used as a positive control in one research paper was used as a negative control in another". [8] As a result of her and her colleague Cyril Labbe's investigations, 17 papers have been retracted, and about five suspicious papers have been noted. [3]

A colleague described the importance of her whistleblowing cancer work as "finding fraud and bad science". [7]

"Projects like Jennifer’s actually are a key part of that. There are a lot more people looking at papers, there are a lot more available online, so people are finding more issues." Undark.org described her work as a "fight for dubious cancer research". [2] Byrne also lost her mother to cancer. [2]

Selected publications

Awards, honours and recognition

Media

Related Research Articles

<span class="mw-page-title-main">Bioinformatics</span> Computational analysis of large, complex sets of biological data

Bioinformatics is an interdisciplinary field of science that develops methods and software tools for understanding biological data, especially when the data sets are large and complex. Bioinformatics uses biology, chemistry, physics, computer science, computer programming, information engineering, mathematics and statistics to analyze and interpret biological data. The subsequent process of analyzing and interpreting data is referred to as computational biology.

<span class="mw-page-title-main">BRCA1</span> Gene known for its role in breast cancer

Breast cancer type 1 susceptibility protein is a protein that in humans is encoded by the BRCA1 gene. Orthologs are common in other vertebrate species, whereas invertebrate genomes may encode a more distantly related gene. BRCA1 is a human tumor suppressor gene and is responsible for repairing DNA.

<span class="mw-page-title-main">UK Biobank</span> Long-term biobank study of 500,000 people

UK Biobank is a large long-term biobank study in the United Kingdom (UK) which is investigating the respective contributions of genetic predisposition and environmental exposure to the development of disease. It began in 2006.

<span class="mw-page-title-main">Splice site mutation</span> Mutation at a location where intron splicing takes place

A splice site mutation is a genetic mutation that inserts, deletes or changes a number of nucleotides in the specific site at which splicing takes place during the processing of precursor messenger RNA into mature messenger RNA. Splice site consensus sequences that drive exon recognition are located at the very termini of introns. The deletion of the splicing site results in one or more introns remaining in mature mRNA and may lead to the production of abnormal proteins. When a splice site mutation occurs, the mRNA transcript possesses information from these introns that normally should not be included. Introns are supposed to be removed, while the exons are expressed.

<span class="mw-page-title-main">Mary-Claire King</span> American geneticist

Mary-Claire King is an American geneticist. She was the first to show that breast cancer can be inherited due to mutations in the gene she called BRCA1. She studies human genetics and is particularly interested in genetic heterogeneity and complex traits. She studies the interaction of genetics and environmental influences and their effects on human conditions such as breast and ovarian cancer, inherited deafness, schizophrenia, HIV, systemic lupus erythematosus and rheumatoid arthritis. She has been the American Cancer Society Professor of the Department of Genome Sciences and of Medical Genetics in the Department of Medicine at the University of Washington since 1995.

<span class="mw-page-title-main">Myriad Genetics</span> American biotechnology company

Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a patient's likelihood of responding to a particular drug therapy, assess a patient's risk of disease progression and disease recurrence, and measure disease activity.

<span class="mw-page-title-main">Roxana Moslehi</span> Genetic epidemiologist

Roxana Moslehi is an Iranian-born genetic epidemiologist.

<span class="mw-page-title-main">CHEK2</span> Protein-coding gene in humans

CHEK2 is a tumor suppressor gene that encodes the protein CHK2, a serine-threonine kinase. CHK2 is involved in DNA repair, cell cycle arrest or apoptosis in response to DNA damage. Mutations to the CHEK2 gene have been linked to a wide range of cancers.

<span class="mw-page-title-main">Biobank</span> Repository of biological samples used for research

A biobank is a type of biorepository that stores biological samples for use in research. Biobanks have become an important resource in medical research, supporting many types of contemporary research like genomics and personalized medicine.

<span class="mw-page-title-main">BARD1</span> Protein-coding gene in the species Homo sapiens

BRCA1-associated RING domain protein 1 is a protein that in humans is encoded by the BARD1 gene. The human BARD1 protein is 777 amino acids long and contains a RING finger domain, four ankyrin repeats, and two tandem BRCT domains.

<span class="mw-page-title-main">LMO2</span> Protein-coding gene in the species Homo sapiens

LIM domain only 2, also known as LMO2, RBTNL1, RBTN2, RHOM2, LIM Domain Only Protein 2, TTG2, and T-Cell Translocation Protein 2, is a protein which in humans is encoded by the LMO2 gene.

<span class="mw-page-title-main">LDB1</span> Protein-coding gene in the species Homo sapiens

LIM domain-binding protein 1 is a protein that in humans is encoded by the LDB1 gene.

<span class="mw-page-title-main">TPD52</span> Protein-coding gene in the species Homo sapiens

Tumor protein D52 is a protein that in humans is encoded by the TPD52 gene.

<span class="mw-page-title-main">LMO4</span> Protein-coding gene in the species Homo sapiens

LIM domain transcription factor LMO4 is a protein that in humans is encoded by the LMO4 gene.

<span class="mw-page-title-main">Maxine Singer</span> American biologist

Maxine Frank Singer is an American molecular biologist and science administrator. She is known for her contributions to solving the genetic code, her role in the ethical and regulatory debates on recombinant DNA techniques, and her leadership of Carnegie Institution of Washington. In 2002, Discover magazine recognized her as one of the 50 most important women in science.

Vanessa Hayes is a geneticist conducting research into cancer genomics and comparative human genomics. She leads a research group at the Garvan Institute of Medical Research in Sydney Australia and holds the Petre Chair of Prostate Cancer Research at the University of Sydney.

<span class="mw-page-title-main">Katherine Belov</span> Australian geneticist

Katherine Belov is an Australian geneticist, professor of comparative genomics in the School of Life and Environmental Sciences and Pro Vice Chancellor of Global Engagement at the University of Sydney. She is head of the Australasian Wildlife Genomics Group and research expert in the area of comparative genomics and immunogenetics, including Tasmanian devils and koalas, two iconic Australian species that are threatened by disease processes. Throughout her career, she has disproved the idea that marsupial immune system is primitive, characterized the South American gray short-tailed opossum's immune genes, participated in the Platypus Genome Project, led research identifying the properties of platypus venom, and identified the cause of the spread of the Tasmanian devil's contagious cancer.

Association for Molecular Pathology v. Myriad Genetics, Inc., 569 U.S. 576 (2013), was a Supreme Court case, which decided, that "a naturally occurring DNA segment is a product of nature and not patent eligible merely because it has been isolated.” However, as a "bizzare conciliatory prize" the Court allowed patenting of complementary DNA, which contains exactly the same protein-coding base pair sequence as the natural DNA, albeit with introns removed.

Douglas F. Easton FMedSci is a British epidemiologist who conducts research on the genetics of human cancers. He is Professor of Genetic Epidemiology and Centre for Cancer Genetic Epidemiology at the University of Cambridge. He founded Cambridge's Cancer Research UK Genetic Epidemiology Unit in 1995, and was a Principal Research Fellow there from 2001 to 2011. He is a Professorial Fellow of Homerton College, Cambridge.

Maria Jasin is a developmental biologist at the Memorial Sloan Kettering Cancer Center. She is known for studying homologous recombination, a method in which double-strand breaks in DNA strands are repaired, and for discovering the role of BRCA1 and BRCA2 in cancers.

References

  1. 1 2 "The structure of the human ribonucleoside diphosphate reductase M1 subunit gene, and use of this locus in studies of embryonal tumours / Jennifer Anne Byrne". University of Queensland Library. Retrieved 17 January 2021.
  2. 1 2 3 4 "Using Software to Fight Cancer Research Fraud". Undark. 2 April 2018. Retrieved 13 August 2019.
  3. 1 2 trevorlstokes, Author (19 January 2017). "What turned a cancer researcher into a literature watchdog?". Retraction Watch. Retrieved 13 August 2019.{{cite web}}: |first= has generic name (help)
  4. ↑ "Professor Jennifer Byrne - St Margaret's". www.stmargarets.qld.edu.au. Retrieved 17 January 2021.
  5. ↑ "Jennifer Anne Byrne - Google Scholar Citations". scholar.google.com.au. Retrieved 13 August 2019.
  6. 1 2 Sydney, The University of. "Professor Jennifer Byrne - The University of Sydney". sydney.edu.au. Retrieved 13 August 2019.
  7. 1 2 3 "The Cancer Researcher Catching Scientific Fraud at Rapid Speed". www.yahoo.com. Retrieved 13 August 2019.
  8. 1 2 Aubusson, Kate (19 December 2017). "Sydney cancer scientist Jennifer Byrne named as one of 10 people who matter in science by Nature". The Sydney Morning Herald. Retrieved 13 August 2019.
  9. ↑ Byrne, Jennifer (6 February 2019). "We need to talk about systematic fraud". Nature. 566 (7742): 9. Bibcode:2019Natur.566....9B. doi: 10.1038/d41586-019-00439-9 . PMID   30728525.
  10. ↑ Sum, Eleanor Y. M.; Peng, Benjamin; Yu, Xin; Chen, Junjie; Byrne, Jennifer; Lindeman, Geoffrey J.; Visvader, Jane E. (18 December 2001). "The LIM Domain Protein LMO4 Interacts with the Cofactor CtIP and the Tumor Suppressor BRCA1 and Inhibits BRCA1 Activity". Journal of Biological Chemistry. 277 (10): 7849–7856. doi: 10.1074/jbc.m110603200 . ISSN   0021-9258. PMID   11751867.
  11. ↑ Chinnaiyan, Arul M.; Sellers, William R.; Collins, Colin; Pienta, Kenneth J.; Byrne, Jennifier A.; Hsi, Bae-Li; Fletcher, Jonathan A.; Kuefer, Rainer; Storz-Schweizer, Martina (1 June 2004). "Overexpression, Amplification, and Androgen Regulation of TPD52 in Prostate Cancer". Cancer Research. 64 (11): 3814–3822. doi: 10.1158/0008-5472.CAN-03-3881 . ISSN   0008-5472. PMID   15172988.
  12. ↑ "Geneticist earns top journal praise".
  13. ↑ "Cancer researcher turned literature watchdog". 19 January 2017.
  14. ↑ "Speakers | Sydney Cancer Conference 2018". scc2018.com.au. Retrieved 13 August 2019.
  15. ↑ "Aussie geneticist earns top journal praise". SBS News. Retrieved 13 August 2019.
  16. ↑ "Nature's 10". www.nature.com. Retrieved 13 August 2019.
  17. ↑ Phillips, Nicky (23 November 2017). "Online software spots genetic errors in cancer papers". Nature News. 551 (7681): 422–423. Bibcode:2017Natur.551..422P. doi: 10.1038/nature.2017.23003 . PMID   29168818.
  18. ↑ "And the winners are…". www.thekidscancerproject.org.au. Retrieved 13 August 2019.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.